Ayesha Rashid
Psychiatry · Houston, TXNPI 1942447610
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $443,547 of the $641,122 with a category attached, or 69.2%. 34 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 28.5% of the total. 2025 is the largest year on record at $209,424, 6.9 times the $30,212 reported in 2019. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,696 payments — averaging $378.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$183K
- AbbVie$176K
- Corium, LLC$165K
- Axsome Therapeutics, Inc.$58K
- Sunovion Pharmaceuticals Inc.$41K
- Neos Therapeutics, LP$6K
- plus $13K from 28 others
What the payments were for
- Consulting fees$46,6907%
- Speaking & faculty fees$443,54769%
- Travel & lodging$120,31819%
- Food & beverage$29,8715%
- Education$6970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$179,290
- VRAYLAR$167,797
- Azstarys$160,935
- Auvelity$56,463
- LATUDA$39,784
- Adzenys XR-ODT$4,408
- Cotempla XR-ODT$4,292
- NEUROSTAR TMS THERAPY$1,472
- ZolpiMist$875
- INGREZZA$431
- SPRAVATO$257
- AUSTEDO$220
- QELBREE$114
- SUNOSI$110
How this compares
$641,122 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 14 | $3,955 |
| Escitalopram Oxalate | 23 | $343 |
| Trazodone Hcl | 20 | $131 |
| Methylphenidate Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$1.5M
- Frank ChenHouston$941K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
- Aaron PetersonHouston$700K
- Lawrence GinsbergHouston$502K
- Kathy FlanaganHouston$443K
- Rayan Al JurdiHouston$359K
- Prashant GajwaniHouston$355K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.